Abstract

Background: Distant metastases are the strongest predictor of poor prognosis in patients with small intestinal neuroendocrine tumors (siNETs). Cytoreductive hepatectomy can improve survival in patients with liver metastases, but the benefit of cytoreductive hepatectomy in patients with extrahepatic metastases is debated and whether to proceed with hepatectomy when peritoneal metastases are encountered intraoperatively is controversial. In this study, we evaluated survival outcomes in patients with liver and peritoneal metastases who underwent cytoreductive hepatectomy.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call